<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127843">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02025075</url>
  </required_header>
  <id_info>
    <org_study_id>Merck-50706</org_study_id>
    <nct_id>NCT02025075</nct_id>
  </id_info>
  <brief_title>Hemodynamic and Respiratory Variations During Laparoscopic Surgery With and Without Deep Neuromuscular Blockade.</brief_title>
  <official_title>A Prospective, Double-blind, Randomized, Crossover Design Study to Compare the Hemodynamic and Respiratory Variations During Laparoscopic Surgery in Patients With and Without Deep Neuromuscular Blockade.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to investigate the effect of depth of neuromuscular block (NMB) on
      global and regional (dependent versus nondependent) respiratory mechanics during
      laparoscopic surgery. Furthermore, we will investigate if the level of NMB influences
      intraoperative hemodynamic and cerebral oxygenation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Ejection fraction (%)</measure>
    <time_frame>The outcome measure will be assessed intraoperatively following introduction of pneumoperitoneum and positioning as the change from the conditions of deep to the condition of mild muscle relaxation as defined by TOF and post-tetanic twitches.</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess cardiac performance, transthoracic echocardiography will be used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Regional change in air content (Delta Z, %)</measure>
    <time_frame>The outcome measure will be assessed intraoperatively following introduction of pneumoperitoneum and positioning as the change from the conditions of deep to the condition of mild muscle relaxation as defined by TOF and post-tetanic twitches.</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will measure continuous respiratory flows and pressures in the intraoperative period to assess continuously the compliance and resistance of the respiratory system (T1 to T5). In addition, we will use an esophageal balloon to assess esophageal pressures and partition the global mechanical properties of the respiratory system, into their lung and chest wall components (T1 to T5). Regional lung aeration will be assessed for quantification of intraoperative lung recruitment using Electrical Impedance Tomography (EIT) (T0 to T6).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral oximetry (%)</measure>
    <time_frame>The outcome measure will be assessed intraoperatively following introduction of pneumoperitoneum and positioning as the change from the conditions of deep to the condition of mild muscle relaxation as defined by TOF and post-tetanic twitches.</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Regional cerebral oxygenation will be assessed continuously during the intraoperative period using NIRS technology.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Postoperative Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>The patient will be inquired about pain with a visual analogue scale (VAS). Pain will be evaluated as abdominal pain, incisional pain, shoulder pain and overall pain using VAS (0 = no pain; 100 = worst possible pain).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Intraoperative Complications</condition>
  <condition>Postoperative Complications</condition>
  <condition>Laparoscopy</condition>
  <condition>Surgical Complications From General Anesthesia</condition>
  <condition>Ventilator-Induced Lung Injury</condition>
  <arm_group>
    <arm_group_label>Deep Neuromuscular Block (NMB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Muscle paralysis with rocuronium 0.6 - 1.2 mg/kg with the dose adjusted to achieve 1-2 post-tetanic counts (neuromuscular function monitor).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Neuromuscular block (NMB)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Muscle paralysis with rocuronium 0.6 - 1.2 mg/kg with the dose adjusted to achieve 1-2 twitches in the train-on-four (neuromuscular function monitor).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Rocuronium 0.6 - 1.2 mg/kg with the dose adjusted to achieve 1-2 post-tetanic counts (Deep NMB) or 1-2 twitches in the train-on-four (Moderate NMB).</description>
    <arm_group_label>Deep Neuromuscular Block (NMB)</arm_group_label>
    <arm_group_label>Moderate Neuromuscular block (NMB)</arm_group_label>
    <other_name>Zemuron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Elective patients scheduled to undergo laparoscopic surgery with expected duration &gt;
             2h

          -  Physical status ASA I - III

        Exclusion Criteria:

          -  Pregnancy

          -  Severe cardiac disease (NYHA class III or IV, acute coronary syndrome, or persistent
             ventricular tachyarrhythmia)

          -  Previous lung surgery

          -  History of severe chronic obstructive pulmonary disease

          -  Gastro-esophageal pathology (including but not limited to recent gastric or
             esophageal surgery including bypass/banding, history of esophageal varices, known
             anatomical gastric or esophageal defects such as strictures, hernias or fistulas)

          -  Mechanical ventilation within the last 30 days

          -  Neuromuscular disease

          -  Consented for another interventional study or refusal to participate in the present
             study

          -  Hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular
             blocking agents
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marcos Vidal Melo, MD, PhD</last_name>
    <phone>617-726-8980</phone>
    <email>VidalMelo.Marcos@mgh.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcos Vidal Melo, MD, PhD</last_name>
      <phone>617-726-8980</phone>
      <email>VidalMelo.Marcos@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Luiz Fernando R Falcao, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Eikermann, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaydev Sarma, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shahin Tabatabaei, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Joris J, Cigarini I, Legrand M, Jacquet N, De Groote D, Franchimont P, Lamy M. Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth. 1992 Oct;69(4):341-5.</citation>
    <PMID>1419439</PMID>
  </reference>
  <reference>
    <citation>Ivankovich AD, Miletich DJ, Albrecht RF, Heyman HJ, Bonnet RF. Cardiovascular effects of intraperitoneal insufflation with carbon dioxide and nitrous oxide in the dog. Anesthesiology. 1975 Mar;42(3):281-7.</citation>
    <PMID>123134</PMID>
  </reference>
  <reference>
    <citation>Dexter SP, Vucevic M, Gibson J, McMahon MJ. Hemodynamic consequences of high- and low-pressure capnoperitoneum during laparoscopic cholecystectomy. Surg Endosc. 1999 Apr;13(4):376-81.</citation>
    <PMID>10094751</PMID>
  </reference>
  <reference>
    <citation>Karsten J, Heinze H, Meier T. Impact of PEEP during laparoscopic surgery on early postoperative ventilation distribution visualised by electrical impedance tomography. Minerva Anestesiol. 2013 Jul 23. [Epub ahead of print]</citation>
    <PMID>23877309</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 9, 2014</lastchanged_date>
  <firstreceived_date>December 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Marcos Vidal Melo</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesia</investigator_title>
  </responsible_party>
  <keyword>Tomography</keyword>
  <keyword>Oximetry</keyword>
  <keyword>Echocardiography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Intraoperative Complications</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Ventilator-Induced Lung Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
